Squarepoint’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,600
Closed -$903K 4657
2025
Q4
$903K Buy
+3,600
New +$956K ﹤0.01% 2709
2025
Q3
Sell
-1,800
Closed -$473K 4706
2025
Q2
$473K Buy
+1,800
New +$438K ﹤0.01% 3326
2023
Q4
Sell
-14,200
Closed -$2.85M 4268
2023
Q3
$2.85M Buy
+14,200
New +$3M 0.01% 1549
2023
Q1
Sell
-3,841
Closed -$777K 3526
2022
Q4
$777K Hold
3,841
﹤0.01% 2006
2022
Q3
$676K Buy
+3,841
New +$786K ﹤0.01% 2038

Other funds holding LH

Squarepoint's LH Position: Q2 2026 in Review

Squarepoint increased its Labcorp (LH) stake by 84% in Q2 2026, buying an estimated $31.1M and bringing the position to 258,438 shares worth $72.4M. The position accounts for 0.08% of the portfolio, ranked #245.

Squarepoint first reported a position in LH in Q2 2015 and has held it in 42 quarters since. 1,058 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Squarepoint held 258,438 shares of Labcorp worth $72.4M as of Q2 2026.
  • Squarepoint bought 118,273 Labcorp shares in Q2 2026, an estimated $31.1M.
  • Labcorp made up 0.08% of Squarepoint's portfolio in Q2 2026, its #245 holding.
  • Squarepoint first reported a position in Labcorp in Q2 2015 and has held it in 42 quarters since.
  • 1,058 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.